Teladoc Health, Inc.

BMV:TDOC * Stock Report

Market Cap: Mex$32.3b

Teladoc Health Future Growth

Future criteria checks 0/6

Teladoc Health is forecast to grow earnings and revenue by 81.4% and 0.8% per annum respectively. EPS is expected to grow by 86.2% per annum. Return on equity is forecast to be -10.9% in 3 years.

Key information

81.4%

Earnings growth rate

86.2%

EPS growth rate

Healthcare Services earnings growth0%
Revenue growth rate0.8%
Future return on equity-10.9%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:TDOC * - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,600-14024137818
12/31/20252,537-15521436325
12/31/20242,566-98817631425
9/30/20242,590-982207338N/A
6/30/20242,609-1,006196333N/A
3/31/20242,619-233200346N/A
12/31/20232,602-220194350N/A
9/30/20232,580-4,002112285N/A
6/30/20232,531-4,01864243N/A
3/31/20232,471-7,05447234N/A
12/31/20222,407-13,66017189N/A
9/30/20222,323-9,86065207N/A
6/30/20222,234-9,871107221N/A
3/31/20222,144-6,90499180N/A
12/31/20212,033-429130194N/A
9/30/20211,862-812-54-4N/A
6/30/20211,629-763-92-49N/A
3/31/20211,367-655-102-65N/A
12/31/20201,094-485-80-54N/A
9/30/2020867-1105980N/A
6/30/2020716-954661N/A
3/31/2020606-981931N/A
12/31/2019553-991930N/A
9/30/2019520-105414N/A
6/30/2019493-108211N/A
3/31/2019457-103-81N/A
12/31/2018418-97-13-5N/A
9/30/2018372-117-22-15N/A
6/30/2018330-125N/A-37N/A
3/31/2018280-115N/A-36N/A
12/31/2017233-107N/A-34N/A
9/30/2017194-77N/A-35N/A
6/30/2017157-75N/A-38N/A
3/31/2017139-75N/A-47N/A
12/31/2016123-74N/A-52N/A
9/30/2016108-75N/A-57N/A
6/30/201696-58N/A-59N/A
3/31/201688-61N/A-54N/A
12/31/201577-58N/A-47N/A
9/30/201568-50N/A-39N/A
6/30/201559-42N/A-24N/A
3/31/201551-29N/A-19N/A
12/31/201444-20N/A-11N/A
12/31/201320-10N/A-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TDOC * is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TDOC * is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TDOC * is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TDOC *'s revenue (0.8% per year) is forecast to grow slower than the MX market (7.2% per year).

High Growth Revenue: TDOC *'s revenue (0.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TDOC * is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y